Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

Share Price is delayed by 15 minutes
Get Live Data
5,410.00    -45.00 (-0.82%)
Bid:
5,405.00
Ask:
5,415.00
Spread: 10.00 (0.185%)
Market Cap: £3.93b
RSW Live PriceLast checked at - London Stock Exchange

Intraday Renishaw Share Chart

Interim Management Statement

17 Oct 2013 10:55

RNS Number : 7496Q
Renishaw PLC
17 October 2013
 



Renishaw plc

Interim management statement

 

This statement has been prepared for the Group and relates to the three months ended 30th September 2013. It contains unaudited information that covers the first quarter and the period since.

 

Trading activity

As highlighted in my year-end statement, in July 2013, the tough comparators facing the Group in the first half of this financial year following record first half revenue last year have proven to be the case with revenue for the three months to 30th September 2013 of £79.0m (2012 £95.9m). Excluding major sales in the first quarter last year, referred to below, we experienced an underlying growth of 9%.

 

By business segment, our metrology business reported revenue of £75.2m, compared with £92.2m for the comparable period last year and our healthcare revenue was similar to last year at £3.8m (2012 £3.7m).

 

Geographically, we experienced good growth of 18% in the Americas and growth of 6% in Europe compared with the corresponding period last year. The Far East, specifically China, continues to be our largest region but revenue suffered a 40% reduction compared with last year, which had benefited from major sales to the consumer electronics industry. The UK, a smaller geographical area in terms of revenue, showed a 9% decrease.

 

The Group cost base in the three months increased by 5% reflecting inflationary increases and expansion of our global marketing and distribution infrastructure. Group headcount at the end of September 2013 was 3,311, an increase of 76 from the 3,235 at the start of the financial year at 1st July 2013, which includes a significant intake of graduates and apprentices.

 

Profit before tax for the first quarter amounted to £10.6m, compared with £27.7m last year as restated from £28.3m to reflect the amendment to accounting standard IAS 19 regarding pension accounting.

 

Significant events and financial position

There has been no significant capital expenditure during the period although at New Mills, the construction of a 120,000 sq ft facility to provide expansion for additional research and development activities, product display, training and conference facilities and the relocation of the spectroscopy product line, commenced in April this year and is progressing, with completion due at the beginning of the next financial year.

 

The Group balance sheet remains strong with net cash balances, excluding the escrow account relating to security for the UK defined benefit pension scheme, at 30th September 2013 of £30.2m (30th June 2013 £26.6m).

 

Board

As already notified in our annual report mailing, Bill Whiteley, the senior independent director, has decided not to seek re-election. Bill has contributed to the growth and success of Renishaw during his 5-year appointment and we wish him every success in the future. We are in the process of recruiting a replacement non-executive director.

 

I am pleased that David Grant has agreed to become acting senior independent director whilst we undergo the recruitment process. Following the new appointment we will review the board composition and assess the senior independent director position at that time.

 

 

Outlook

It is very early in our financial year and our order book as usual remains at approximately one month's revenue. Whilst we may continue to experience unpredictable orders both in terms of size and timing we expect continued global investment in production systems and processes to lead to greater demand for the Group's products. We therefore continue to invest in our infrastructure, research and development and remain confident for the medium to longer-term prospects for the Group.

 

 

 

Sir David McMurtry CBE, RDI, FRS, FREng, CEng, FIMechE

Chairman and Chief Executive

 

17th October 2013

 

Renishaw plc

Registered office New Mills, Wotton-under-Edge, Gloucestershire, GL12 8JR

Registered number 1106260

Telephone number 01453 524524

Website www.renishaw.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSMRBLTMBABMJJ
Date   Source Headline
6th May 20267:00 amRNSTrading Statement
20th Apr 20267:00 amRNSTrading Statement
8th Apr 20267:00 amRNSBoard Changes
11th Feb 20267:00 amRNSHalf-year Financial Report
29th Jan 202612:00 pmRNSNotice of Half-year Results
28th Nov 202511:00 amRNSHolding(s) in Company
28th Nov 202511:00 amRNSHolding(s) in Company
27th Nov 20256:29 pmRNSHolding(s) in Company
27th Nov 20255:00 pmRNSDirector/PDMR Shareholding
26th Nov 20251:32 pmRNSResult of AGM
26th Nov 20258:30 amRNSShareholdings update
29th Oct 20254:00 pmRNSDirector/PDMR Shareholding
23rd Oct 20254:00 pmRNSDirector/PDMR Shareholding
23rd Oct 20257:00 amRNSTrading Statement
21st Oct 20253:02 pmRNSVoting Arrangement
21st Oct 20253:00 pmRNSHolding(s) in Company
21st Oct 20253:00 pmRNSHolding(s) in Company
3rd Oct 20257:00 amRNSAnnual Financial Report
24th Sep 20257:00 amRNSDirector/PDMR Shareholding
23rd Sep 20257:00 amRNSNew reporting segments for FY2026
18th Sep 20257:00 amRNSFinal Results
21st Aug 20257:00 amRNSBoard Change and Trading Update
13th Aug 20257:00 amRNSDirectorate Change
17th Jun 20257:00 amRNSCapital Markets Day
8th May 20257:00 amRNSTrading Statement
14th Apr 20259:49 amRNSDirector/PDMR Shareholding
13th Feb 20257:00 amRNSHalf-year Report
9th Dec 20242:02 pmRNSDeath of Sir David McMurtry
27th Nov 20242:44 pmRNSResult of AGM
29th Oct 20241:28 pmRNSDirector/PDMR Shareholding
24th Oct 20247:00 amRNSTrading Statement
27th Sep 20247:15 amRNSAnnual Financial Report
12th Sep 20247:00 amRNSFinal Results
29th Aug 20242:00 pmRNSNotice of Results
1st Jul 20247:00 amRNSDirectorate Change
13th Jun 20247:00 amRNSDirectorate Change
16th May 20242:25 pmRNSAGM Voting Results Update Statement
8th May 20247:00 amRNSTrading Statement
2nd Apr 20245:19 pmRNSStatement regarding Renishaw plc
6th Feb 20247:00 amRNSHalf-year Report
30th Jan 202410:30 amRNSChange of Adviser
23rd Jan 20249:00 amRNSNotice of Half-year Results
29th Nov 20232:47 pmRNSResult of AGM
26th Oct 20237:00 amRNSTrading Statement
13th Oct 20237:00 amRNSNotice of AGM
3rd Oct 20237:00 amRNSAnnual Financial Report
19th Sep 20237:00 amRNSFinal Results
13th Sep 20237:00 amRNSRevised date for publication of results
21st Aug 20233:00 pmRNSDirectorate Change
12th Jul 20232:30 pmRNSVoting Arrangement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.